Oxford Nanopore Technologies (CHIX:ONTL) LT-Debt-to-Total-Asset : 0.06 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Oxford Nanopore Technologies's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.06.

Oxford Nanopore Technologies's long-term debt to total assets ratio increased from Jun. 2023 (0.02) to Jun. 2024 (0.06). It may suggest that Oxford Nanopore Technologies is progressively becoming more dependent on debt to grow their business.

Oxford Nanopore Technologies LT-Debt-to-Total-Asset Historical Data

The historical data trend for Oxford Nanopore Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies LT-Debt-to-Total-Asset Chart

Oxford Nanopore Technologies Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.10

0.08

0.03

0.04

0.05

Oxford Nanopore Technologies Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial						0.02	0.04	0.02	0.05	0.06

Oxford Nanopore Technologies LT-Debt-to-Total-Asset Calculation

Oxford Nanopore Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	37.333	/	777.062
	=	0.05

Oxford Nanopore Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )	/	Total Assets (Q: Jun. 2024 )
	=	41.578	/	722.653
	=	0.06

Oxford Nanopore Technologies (CHIX:ONTl) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Oxford Nanopore Technologies LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Nanopore Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (CHIX:ONTl) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

OXFYY:USA ONTTF:USA ONT:UK 4R0:Germany

Address

Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX4 4DQ

Website

https://www.nanoporetech.com

Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.

Oxford Nanopore Technologies Headlines

No Headlines